GlassScriptPhysician profile
Gerald M Pritcher
NPI 1295776193
$2,952.42
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,513 · 2020: $1,354 · 2021: $40.85 · 2022: $44.02.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $489.25 | 2019-2020 | |
| Glaxosmithkline, LLC. | $313.71 | 2019-2020 | |
| Novo Nordisk INC | $271.04 | 2019-2020 | |
| Pfizer INC. | $262.32 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $220.12 | 2019-2020 | |
| Abbvie INC. | $200.86 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.55 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $149.98 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $102.66 | 2019-2020 | |
| Amgen INC. | $84.13 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $68.45 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $57.03 | 2019-2020 | |
| Astellas Pharma US INC | $56.23 | 2019-2020 | |
| Amarin Pharma, INC. | $55.36 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $51.44 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $50.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.83 | 2019-2020 | |
| Lilly USA, LLC | $40.14 | 2019 | |
| Genentech USA, INC. | $17.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.90 | 2020 | |
| Sanofi Pasteur INC. | $15.00 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.04 | 2019 | |
| Abbott Laboratories | $12.83 | 2019 | |
| Welch Allyn | $12.77 | 2020 | |
| Eisai INC. | $12.64 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,936.69 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Pritcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.